Multinational pharmaceutical companies analyzed that they would not receive greater benefit from certification business of innovative pharmaceutical company
Recently, 20 pharmaceutical companies submitted application for the second certification business of innovative pharmaceutical company. Among them, the number of multinational pharmaceutical company was only 5 companies including Novartis, Sanofi-Aventis Korea, AstraZeneca, Roche, and Boehringer ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
